Rheumatology in India - Quo vadis?

Nature Reviews Rheumatology

Volumn 11, Issue 3, 2015, Pages 183-188

  Handa, Rohini ^a  

^a INDRAPRASTHA APOLLO HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BENZATHINE PENICILLIN; GOLIMUMAB; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PENICILLAMINE; RITUXIMAB; SALAZOSULFAPYRIDINE; TOCILIZUMAB; ANTIRHEUMATIC AGENT;

ALTERNATIVE MEDICINE; ANKYLOSING SPONDYLITIS; ANTIBODY TITER; AYURVEDA; BRUCELLOSIS; CHIKUNGUNYA; CLINICAL FEATURE; COMORBIDITY; DENGUE; DIAGNOSTIC ERROR; GOUT; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH SERVICE; HUMAN; INDIA; JUVENILE RHEUMATOID ARTHRITIS; KNEE OSTEOARTHRITIS; LEPTOSPIROSIS; LOADING DRUG DOSE; LOW DRUG DOSE; MEDICAL EDUCATION; MEDICAL RESEARCH; MELIOIDOSIS; NONARTICULAR RHEUMATISM; PATIENT CARE; PATIENT EDUCATION; PREGNANCY OUTCOME; PREVALENCE; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; QUALITY OF LIFE; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SEX DIFFERENCE; SPONDYLARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; COST OF ILLNESS; ECONOMICS; EDUCATION; ORGANIZATION AND MANAGEMENT; RHEUMATIC DISEASES; STANDARDS; TRENDS;

ANTIRHEUMATIC AGENTS; COST OF ILLNESS; HUMANS; INDIA; RHEUMATIC DISEASES; RHEUMATOLOGY;

EID: 84924179606     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2014.182     Document Type: Review

References (72)

1. Ministry of Health and Family Welfare, Government of India. Census 2001 and 2011-Key indicators [online], http://www.mohfw.nic.in/showfile.php?lid=2019 (2014
2. World Health Organization. Global Health Observatory Data Repository. Life expectancy data by country [online], http://apps.who.int/gho/data/node.main.688?lang=en (2012
3. WHO-Ministry of Health and Family Welfare, Government of India. National action plan and monitoring framework for prevention and control of noncommunicable diseases (NCDs) in India. WHO-Government of India 2012-2013 Biennial Workplan [online], http://www.searo.who.int/india/topics/cardiovascular-diseases/National-Action-Plan-and-Monitoring-Framework-Prevention-NCDs.pdf?ua=1 (2014
4. Chopra, A. COPCORD-An unrecognized fountainhead of community rheumatology in developing countries. J. Rheumatol. 31, 2320-2323 (2004
5. Chopra, A., Patil, J., Billempelly, V., Relwani, J. & Tandle, H. S. Prevalence of rheumatic diseases in a rural population in western India: a WHO-ILAR COPCORD study. J. Assoc. Physicians India 49, 240-246 (2001
6. Joshi, V. L. & Chopra, A. Is there an urban-rural divide? Population surveys of rheumatic musculoskeletal disorders in the Pune region of India using the COPCORD Bhigwan model. J. Rheumatol 36, 614-622 (2009
7. Malaviya, A. N., Kapoor, S. K., Singh, R. R., Kumar, A. & Pande, I. Prevalence of rheumatoid arthritis in the adult Indian population. Rheumatol. Int. 13, 131-134 (1993
8. Central Intelligence Agency. The World Factbook. https://www.cia.gov/library/publications/the world factbook/fields/2010.html (2014
9. Lagu-Joshi, V., Chanchani, E., Saluja, M., Anuradha, V. & Chopra, A. Prevalence of rheumatic musculoskeletal disorders (RMSK) in a West Indian urban population: a bone and joint decade (BJD) India Burden of Disease Project. American College of Rheumatology [online] https://acr.confex.com/acr/2007/webprogram/Paper7531.html (2007
10. Chopra, A. & Abdel-Nasser. A. Epidemiology of rheumatic musculoskeletal disorders in the developing world. Best Pract. Res. Clin. Rheumatol. 22, 583-604 (2008
11. Malaviya, A. N., Singh. R. R., Singh, Y. N., Kapoor, S. K. & Kumar, A. Prevalence of systemic lupus erythematosus in India. Lupus 2, 115-118 (1993
12. Malaviya, A. N., et al. Indian Rheumatology Association consensus statement on the diagnosis and treatment of axial spondyloarthropathies. Ind. J. Rheumatol. 5, 16-34 (2010
13. Dey, A. B. & Handa, R. Action Plan Osteoporosis. (Osteoporosis Society of India, New Delhi, 2003
14. Handa, R., Kalla, A. A. & Maalouf, G. Osteoporosis in developing countries. Best Pract. Res. Clin. Rheumatol. 22, 693-708 (2008
15. Malaviya, A. N., et al. Clinical and immunogenetic studies in rheumatoid arthritis from northern India. Rheumatol. Int. 3, 105-108 (1983
16. Aggarwal, R. & Malaviya, A. N. Clinical characteristics of patients with ankylosing spondylitis in India. Clin. Rheumatol. 28, 1199-1205 (2009
17. Sobti, P. & Bhasin, R. C. Gout in India. (A study of clinical features). J. Assoc. Physicians India 16, 961-965 (1968
18. Malaviya, A. N., Chandrasekaran, A. N., Kumar, A. & Shamar, P. N. Systemic lupus erythematosus in India. Lupus 6, 690-700 (1997
19. Aggarwal, R. & Malaviya, A. N. Diagnosis delay in patients with ankylosing spondylitis: factors and outcomes-An Indian perspective. Clin. Rheumatol. 28, 327-331 (2009
20. Handa, R., Wali, J. P., Biswas, A., Aggarwal, P. & Wig, N. Wegeners granulomatosis-A clinicopathologic study. J. Assoc. Physicians India 45, 536-539 (1997
21. Handa, R., Farooqi, A. Z., Haq, S. A. & Wali, J. P. Wegeners granulomatosis in the Indian Subcontinent. APLAR J. Rheumatol. 2, 210-215 (1999
22. Hadda, V., et al. Disease activity and lipids in rheumatoid arthritis: a prospective study. Ind. J. Rheumatol. 2, 137-140 (2007
23. Mahajan, V., et al. Assessment of atherosclerosis by carotid intimomedial thickness in patients with rheumatoid arthritis. J. Assoc. Physicians India 56, 587-590 (2008
24. Grover, S., et al. Subclinical atherosclerosis in rheumatoid arthritis in India. J. Rheumatol. 33, 244-247 (2006
25. Bhatt, S. P., et al. Atherosclerosis in Asian Indians with systemic lupus erythematosus. Scand. J. Rheumatol. 35, 128-132 (2006
26. Ghosh, P., et al. Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus. Clin. Rheumatol. 28, 1259-1265 (2009
27. Shankar, S., et al. Bone mineral density in Indian women with rheumatoid arthritis. Rheumatol. Int. 29, 377-381 (2009
28. Gokhale, Y. A., Bichile, L. S., Gogate, A., Tillu, A. V. & Zamre. Brucella spondylitis: an important treatable cause of low backache. J. Assoc. Physicians India 47, 384-388 (1999
29. Kochar, D. K., et al. Hospital-based case series of 175 cases of serologically confirmed brucellosis in Bikaner. J. Assoc. Physicians India 55, 271-275 (2007
30. Chopra, A., Anuradha, V., Ghorpade, R. & Saluja, M. Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2 year prospective rural community study. Epidemiol. Infect. 140, 842-850 (2012
31. Taraphdar, D., Sarkar, A., Mukhopadhyay, B. B., Chakrabarti, S. & Chatterjee, S. Rapid spread of chikungunya virus following its resurgence during 2006 in West Bengal, India. Trans. R. Soc. Trop. Med. Hyg. 106, 160-166 (2012
32. Mathew, A. J., et al. Rheumatic-musculoskeletal pain and disorders in a naïve group of individuals 15 months following a Chikungunya viral epidemic in south India: a population based observational study. Int. J. Clin. Pract. 65, 1306-1312 (2011
33. Chopra, A., Saluja, M. & Venugopalan, A. Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. Arthritis Rheumatol. 66, 319-326 (2014
34. Sethi S., et al. Increasing trends of leptospirosis in Northern India: a clinico-epidemiological study. PLoS Negl. Trop. Dis. 4, e579 (2010
35. Adebajo, A. O. Dengue arthritis. Br. J. Rheumatol. 35, 909-910 (1996
36. Talib, S., Bhattu, S., Bhattu, R., Deshpande, S. & Dahiphale, D. Dengue fever triggering systemic lupus erythematosus and lupus nephritis: a case report. Int. Med. Case Rep. J. 6, 71-75 (2013
37. Rajadhyaksha, A. & Mehra, S. Dengue fever evolving into systemic lupus erythematosus and lupus nephritis: a case report. Lupus 21, 999-1002 (2012
38. Handa, R., Wali, J. P., Singh, S. & Aggarwal, P. A prospective study of Lyme arthritis in north India. Ind. J. Med. Res. 110, 107-109 (1999
39. Shyam, C. & Malaviya, A. N. Infection-related morbidity in systemic lupus erythematosus: a clinico-epidemiological study from northern India. Rheumatol. Int. 16, 1-3 (1996
40. Dhir, V., Aggarwal, A., Lawrence, A., Agarwal, V. & Misra, R. Long-Term outcome of lupus nephritis in Asian Indians. Arthritis Care Res. (Hoboken) 64, 713-720 (2012
41. Bedi, G. S., Gupta, N., Handa, R., Pal, H. & Pandey, R. M. Quality of life in Indian patients with rheumatoid arthritis. Qual. Life Res. 14, 1953-1958 (2005
42. Khanna, S., Pal, H., Pandey, R. M. & Handa, R. The relationship between disease activity and quality of life in systemic lupus erythematosus. Rheumatology (Oxford) 43, 1536-1540 (2004
43. Haroon, N., Aggarwal, A., Lawrence, A., Agarwal, V. & Misra, R. Impact of rheumatoid arthritis on quality of life. Mod. Rheumatol. 17, 290-295 (2007
44. Kumar, A. Indian Guidelines on the management of SLE. J. Indian Rheumatol. Assoc. 10, 80-96 (2002
45. Misra, R., et al. Indian Rheumatology Association consensus statement on the management of adults with rheumatoid arthritis. Indian J. Rheumatol. 3 (Suppl.), S1-S16 (2008
46. Venkataraman, K., et al. Indian Rheumatology Association guidelines for management of glucocorticoid-induced osteoporosis. Endorsed by: Endocrine Society of India and Indian Society for Bone & Mineral Research. Indian J. Rheumatol. 6, 68-75 (2011
47. Agarwal, S., Zaman, T. & Handa, R. Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. Singapore Med. J. 50, 686-692 (2009
48. Kumar, A. Experience with anti-Tumor necrosis factor α therapy in India. APLAR J. Rheumatol. 9, 136-141 (2006
49. Chaturvedi, V. P. & Singal, V. K. (2004). No case of tuberculosis with low dose infliximab without loading dose in ankylosing spondylitis-retrospective analysis of 108 cases. Presented at the 11th Asia Pacific League of Associations for Rheumatology (APLAR) Congress 2004
50. Handa, R., et al. Guidelines for tuberculosis prophylaxis during anti-Tumour necrosis factor α treatment: Indian Rheumatology Association. APLAR J. Rheumatol. 9, 181-183 (2006
51. Indian Rheumatology Association. Indian Rheumatology Association Biologics Registry [online] http://www.irabr.org (2010
52. Aggarwal, A. & Sawhney, S. From the Editors desk. Ind. J. Rheumatol. 7 (Suppl.), iv (2012
53. Aggarwal, A., Agarwal, V., Danda, D. & Misra, R. Outcome in juvenile rheumatoid arthritis in India. Indian Pediatr. 41, 180-184 (2004
54. Sawhney, S. Spectrum of juvenile idiopathic arthritis in a tertiary care centre in northern India. Ind. J. Rheumatol. 14, 3-6 (2006
55. Singh, S., et al. Clinico-immunological profile of juvenile rheumatoid arthritis at Chandigarh. Indian Pediatr. 36, 449-454 (1999
56. Chandrasekaran, A. N., Rajendran, C. P. & Madhavan, R. Juvenile rheumatoid arthritis-Madras experience. Indian J. Pediatr. 63, 501-510 (1996
57. Aggarwal, A. & Misra, R. N. Juvenile rheumatoid arthritis in India-rarity of antinuclear antibody and uveitis. Indian J. Pediatr. 63, 301-304 (1996
58. Sawhney, S. & Manners, P. The place of pediatric rheumatology in India. Ind. J. Pediatr. 77, 993-996 (2010
59. Kumar, A., et al. Survival in patients with systemic lupus erythematosus in India. Rheumatol. Int. 12, 107-109 (1992
60. Murali, R., et al. Systemic lupus erythematosus in Indian patients: Prognosis, survival and life expectancy. Natl Med. J. India 10, 159-164 (1997
61. Sharma, A., et al. Causes of mortality among in patients with systemic lupus erythematosus in a tertiary care hospital in North India over a 10 year period. Lupus 22, 216-222 (2013
62. Gupta, A., Agarwal, A. & Handa, R. Pregnancy in Indian patients with systemic lupus erythematosus. Lupus 14, 926-927 (2005
63. Aggarwal, A., Chandran, S. & Misra, R. Physical, psychosocial and economic impact of rheumatoid arthritis: a pilot study of patients seen at a tertiary care referral centre. Natl Med. J. India 19, 187-191 (2006
64. Zaman, T., Agarwal, S. & Handa, R. Complementary and alternative medicine use in rheumatoid arthritis-An audit of patients visiting a tertiary care centre. Natl Med. J. India 20, 236-239 (2007
65. Rao, P. & Prasanna, N. M. Immunological studies on rheumatoid arthritis treated with homeopathic drugs: results of the pilot study. Ind. J. Res. Homoeopathy 2, 42-49 (2008
66. Chopra, A. Ayurvedic medicine and arthritis. Rheum. Dis. Clin. North Am. 26, 133-144 (2000
67. Chopra, A. & Doiphode, V. V. Ayurvedic medicine. Core concept, therapeutic principles, and current relevance. Med. Clin. North Am. 86, 75-89 (2002
68. Basnyat, S. & Kolasinski, S. L. Ayurvedic medicine for rheumatoid arthritis. Curr. Rheumatol. Rep. 16, 435 (2014
69. Chopra, A., et al Randomized controlled exploratory evaluation of standardized ayurvedic formulations in symptomatic osteoarthritis knees: a government of India NMITLI project. Evid. Based Complement. Alternat. Med. 2011, 724291 (2011
70. Chopra, A., et al. Comparable efficacy of standardized Ayurveda formulation and hydroxychloroquinesulfate (HCQS) in the treatment of rheumatoid arthritis (RA): a randomized investigator-blind controlled study. Clin. Rheumatol. 31, 259-269 (2012
71. Chopra, A., et al. Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial. Rheumatology (Oxford) 52, 1408-1417 (2013
72. Handa R. Rheumatology in postgraduate curriculum. Indian J. Rheumatol. 9, 127-130 (2014